SLC2A4 and Glucose intolerance: However, rapamycin-treated HFD-fed mice showed increased glucose intolerance due to lower basal insulin levels, decreased expression levels of GLUT4 in the adipose tissue and, in the liver, decreased lipogenesis and increased gluconeogenesis (Figures S1D and S4).